← Back to Portfolio

Kesios Therapeutics

Kesios, a spin-out from Imperial College London, was developing novel oncology therapeutics for multiple myeloma. The underlying technology did not show sufficient efficacy, and as a result, the company is closing down.

Location London, UK
Website www.kesios.com